Featured Products
Thermo Scientific™ inSPIRE™ Collaborative Laboratory Automation Platform
Featured ProductThermo Fisher Scientific
READ MORE
Product News
Custom CAR-T Development Service
AMSBIO has announced a custom Chimeric Antigen Receptor T cell (CAR-T) service designed to take advantage of the clinical breakthroughs achieved with CAR-T cells in various hematological malignancies.
READ MORE
Configurable LIMS Highlighted at PITTCON
The latest version of Matrix Gemini LIMS from Autoscribe Informatics will be on show at PITTCON 2020.
READ MORE
Proscia® Granted U.S. Patent for Computer-implemented Method of Evaluating Medical Images
Proscia® has been granted a U.S. patent relating to techniques for evaluating medical images, including whole slide images.
READ MORE
Microbial Bioburden Testing With Milliflex Oasis® System
Merck has launched its latest pharmaceutical bioburden and water testing product, the Milliflex Oasis® System.
READ MORE
Minimizing Wastage with Waterless Air Condensers
Chemistry labs, seeking to minimize water wastage, are electing to replace Liebig-style water condensers with waterless air condenser, such as the Asynt CondenSyn.
READ MORE
Next Generation Phospholipid Removal Microplate
Porvair Sciences have announced Microlute PLR, a new product for phospholipid removal.
READ MORE
Supporting Reduction of Anemia in Developing Regions in South America
A new symposium highlights the use of EKF’s Hemo Control hemoglobin analyzer in the fight to reduce chronic child malnutrition in South America.
READ MORE
DrChrono Closes $20M to Grow Practice Management Platform
DrChrono has announced it has raised a $20 million growth capital round from ORIX Growth Capital to spur the expansion of its technology platform (EHR, medical billing and API).
READ MORE
Additional Funding Awarded for Regenerative Cartilage Therapy Development
Mogrify has announced that it has secured $1.1M of additional funding from SBRI Healthcare to assess its regenerative cartilage therapy.
READ MORE
TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-concept
Avacta, the developer of Affimer® biotherapeutics and reagents, has announced that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate.
READ MORE
